MONOKLONALER INTERLEUKIN-31-ANTIKÖRPER
European patent · EP4459282 · In force
Register entry
- Publication number
- EP4459282
- Application number
- EP24200176
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 5, 2012
- Published
- Nov 6, 2024
- Granted
- Oct 22, 2025
- Protection ends at the latest
- Jul 4, 2032
- Next annual fee due
- Jul 31, 2027
- IPC classes
- C07K 16/24 (2006.01)G01N 33/53 (2006.01)
- Priority
- US 201161510268 P 21.07.2011
- Divided from
- EP20194926
- Filing language
- English
- Source
- Swissreg
Supplementary protection certificates
A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 2, 2026
Change
Published in Swissreg on 02.09.2026
- Aug 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.07.2026 → 31.07.2027
Published in Swissreg on 01.08.2026
- Nov 25, 2025
Agent entered
- Representative
- E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich
Published in Swissreg on 25.11.2025
- Oct 22, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 22.10.2025
Parties
Inventor
Bammert, Gary F.
Kalamazoo, MI 49007, US
Dunham, Steven A.
Kalamazoo, MI 49007, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.